Literature DB >> 27512097

Adipose-specific inactivation of JNK alleviates atherosclerosis in apoE-deficient mice.

Kelvin H M Kwok1, Kenneth K Y Cheng1, Ruby L C Hoo1, Dewei Ye1, Aimin Xu2, Karen S L Lam3.   

Abstract

Both atherosclerosis and obesity, an independent atherosclerotic risk factor, are associated with enhanced systemic inflammation. Obesity is also characterized by increased adipose tissue inflammation. However, the molecular mechanism underlying the accelerated atherosclerosis in obesity remains unclear. In obesity, activation of c-Jun N-terminal kinase (JNK) contributes to adipose tissue inflammation. The present study investigated whether the suppression of fat inflammation through adipose-specific JNK inactivation could protect against atherosclerosis in mice. ApoE-/- mice were cross-bred with transgenic mice with adipose-specific expression of a dominant negative form of JNK (dnJNK) to generate apoE-/-/dnJNK (ADJ) mice. ADJ mice treated with a high-fat-high-cholesterol diet exhibited significant attenuations of visceral fat and systemic inflammation without changes in lipid or glucose metabolism, and were protected against atherosclerosis, when compared with apoE-/- mice. Lean apoE-/- mice that received transplantation of visceral fat from obese wild-type donor mice for 4 weeks showed exacerbated systemic inflammation and atherosclerotic plaque formation. Conversely, apoE-/- recipients carrying a visceral fat graft from obese dnJNK donors were protected against enhanced systemic inflammation and atherogenesis. The beneficial effects of adipose-specific JNK inactivation on atherogenesis in apoE-/- recipients were significantly compromised by continuous infusion of recombinant adipocyte-fatty acid-binding protein (A-FABP), previously shown to interact with JNK via a positive feedback loop to modulate inflammatory responses. Together these data suggested that enhanced atherosclerosis in obesity can be attributed, at least in part, to a distant cross-talk between visceral fat and the vasculature, mediated by the release of proinflammatory cytokines, such as A-FABP, from the inflamed visceral adipose tissue with JNK activation.
© 2016 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  JNK; adipose tissue; atherosclerosis; inflammation; obesity

Mesh:

Substances:

Year:  2016        PMID: 27512097     DOI: 10.1042/CS20160465

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

1.  Prospective associations of circulating adipocyte fatty acid-binding protein levels with risks of renal outcomes and mortality in type 2 diabetes.

Authors:  Chi Ho Lee; Chloe Y Y Cheung; Yu Cho Woo; David T W Lui; Michele M A Yuen; Carol H Y Fong; Wing Sun Chow; Amin Xu; Karen S L Lam
Journal:  Diabetologia       Date:  2018-09-28       Impact factor: 10.122

2.  Visceral, general, abdominal adiposity and atherogenic index of plasma in relatively lean hemodialysis patients.

Authors:  Chaomin Zhou; Hongying Peng; Jing Yuan; Xin Lin; Yan Zha; Hui Chen
Journal:  BMC Nephrol       Date:  2018-08-16       Impact factor: 2.388

3.  Galectin-3 exacerbates ox-LDL-mediated endothelial injury by inducing inflammation via integrin β1-RhoA-JNK signaling activation.

Authors:  Xiumei Chen; Jianzhong Lin; Tingting Hu; Zhiyun Ren; Linnan Li; Irbaz Hameed; Xiaoyu Zhang; Chen Men; Yan Guo; Di Xu; Yiyang Zhan
Journal:  J Cell Physiol       Date:  2018-12-10       Impact factor: 6.384

4.  Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis.

Authors:  Szilárd Póliska; Timea Besenyei; Edit Végh; Attila Hamar; Anita Pusztai; Andrea Váncsa; Nóra Bodnár; Szilvia Szamosi; Mária Csumita; György Kerekes; Zoltán Szabó; Zoltán Nagy; Gabriella Szűcs; Sándor Szántó; Gábor Zahuczky; László Nagy; Zoltán Szekanecz
Journal:  Arthritis Res Ther       Date:  2019-04-15       Impact factor: 5.156

Review 5.  JNK and cardiometabolic dysfunction.

Authors:  Siobhan M Craige; Kai Chen; Robert M Blanton; John F Keaney; Shashi Kant
Journal:  Biosci Rep       Date:  2019-07-18       Impact factor: 3.840

Review 6.  Adipocyte Fatty Acid-Binding Protein, Cardiovascular Diseases and Mortality.

Authors:  Chi-Ho Lee; David T W Lui; Karen S L Lam
Journal:  Front Immunol       Date:  2021-03-19       Impact factor: 7.561

7.  Editorial: The Immunomodulatory Roles of Adipocytes.

Authors:  David Bradley; Aimin Xu; Willa A Hsueh
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

8.  Retraction.

Authors: 
Journal:  J Cell Mol Med       Date:  2022-01-10       Impact factor: 5.310

Review 9.  NLRP3 Inflammasome Activation in Adipose Tissues and Its Implications on Metabolic Diseases.

Authors:  Kelvin Ka-Lok Wu; Samson Wing-Ming Cheung; Kenneth King-Yip Cheng
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.